Literature DB >> 6393615

Lyme disease in Minnesota: epidemiologic and serologic findings.

M T Osterholm, J C Forfang, K E White, J N Kuritsky.   

Abstract

During the four years, 1980 to 1983, 83 Minnesota residents have been diagnosed with Lyme disease. Sixty-five of the patients were male. The median age of patients was 39 years with a range from one to 77 years. Seventy-five (90 percent) had onset in 1982 and 1983. Of these latter cases, 56 (75 percent) recalled a tick bite three to 27 days prior to the development of erythema chronicum migrans. Patients experienced possible exposure to Ixodes dammini in at least 24 (28 percent) of the 87 Minnesota counties; however, over 50 percent had reported exposure in one of eight east-central counties near or immediately west of the Wisconsin border. Serologic studies for antibody against the Ixodes dammini spirochete were completed on 30 patients with onset in 1982 and 1983. Of 28 patients with paired acute and convalescent serum samples, only two (7 percent) had fourfold rises in antibody titers. Lyme disease is an emerging public health problem in Minnesota. Additional studies are needed to define the risk of disease by geographic area within the state. Physicians statewide should be alert to the possibility of Lyme disease among their patients, since only 39 percent of patients with onset in 1982 and 1983 were exposed in their county of residence.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6393615      PMCID: PMC2589986     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  23 in total

1.  The reporting of communicable diseases.

Authors:  R Marier
Journal:  Am J Epidemiol       Date:  1977-06       Impact factor: 4.897

2.  Neurologic abnormalities of Lyme disease.

Authors:  L Reik; A C Steere; N H Bartenhagen; R E Shope; S E Malawista
Journal:  Medicine (Baltimore)       Date:  1979-07       Impact factor: 1.889

3.  Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.

Authors:  A C Steere; S E Malawista; J A Hardin; S Ruddy; W Askenase; W A Andiman
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

4.  Completeness of statutory notification for acute bacterial meningitis.

Authors:  M J Goldacre; D L Miller
Journal:  Br Med J       Date:  1976-08-28

5.  Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector.

Authors:  A C Steere; T F Broderick; S E Malawista
Journal:  Am J Epidemiol       Date:  1978-10       Impact factor: 4.897

6.  Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini.

Authors:  A C Steere; S E Malawista
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

7.  Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

Authors:  A C Steere; S E Malawista; D R Snydman; R E Shope; W A Andiman; M R Ross; F M Steele
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

8.  Shigella surveillance in a large metropolitan area: assessment of a passive reporting system.

Authors:  A M Kimball; S B Thacker; M E Levy
Journal:  Am J Public Health       Date:  1980-02       Impact factor: 9.308

9.  Antibiotic therapy in Lyme disease.

Authors:  A C Steere; S E Malawista; J H Newman; P N Spieler; N H Bartenhagen
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

10.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.

Authors:  L B Schonberger; D J Bregman; J Z Sullivan-Bolyai; R A Keenlyside; D W Ziegler; H F Retailliau; D L Eddins; J A Bryan
Journal:  Am J Epidemiol       Date:  1979-08       Impact factor: 4.897

View more
  2 in total

1.  Intra- and interlaboratory reproducibility of an ELISA serological test for Lyme disease.

Authors:  M C Tammemagi; J W Frank; M Leblanc; H Artsob
Journal:  Can J Infect Dis       Date:  1995-03

2.  Interlaboratory and intralaboratory comparisons of indirect immunofluorescence assays for serodiagnosis of Lyme disease.

Authors:  R S Lane; E T Lennette; J E Madigan
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.